DNA-PK Inhibition Enhances Neoantigen Diversity and Increases T Cell Responses to Immunoresistant Tumors

Investigators identified DNA-PK inhibitor NU7441 as a promising immunomodulator that reduced immunosuppressive proteins while increasing MHC-I expression in a panel of human melanoma cell lines.